Differential Expression Analysis
FL13 / WBM Comparison
Note: The Fold Change value for up-regulated genes is displayed in red; down-regulated values are displayed in blue.
Gene | Annotation | pval | Fold Change (log2ratio) |
---|---|---|---|
h19 | H19 fetal liver mRNA | 3.547e-6 | 5.832e+0 |
loc100047856 | similar to calponin 3, acidic | 3.843e-6 | 5.125e+0 |
mpo | myeloperoxidase | 4.369e-6 | 4.669e+0 |
dkk1 | dickkopf homolog 1 (Xenopus laevis) | 1.580e-9 | 4.375e+0 |
cnn3 | calponin 3, acidic | 1.061e-5 | 4.210e+0 |
igf2 | insulin-like growth factor 2 | 1.315e-4 | 4.143e+0 |
bc015286 | cDNA sequence BC015286 | 6.543e-8 | 4.006e+0 |
ddx4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 1.423e-5 | 3.839e+0 |
igf2bp1 | insulin-like growth factor 2 mRNA binding protein 1 | 6.372e-9 | 3.792e+0 |
postn | periostin, osteoblast specific factor | 9.041e-5 | 3.620e+0 |
hmga2 | high mobility group AT-hook 2 | 1.807e-8 | 3.602e+0 |
pik3r6 | phosphoinositide-3-kinase, regulatory subunit 6 | 7.155e-5 | 3.554e+0 |
dlk1 | delta-like 1 homolog (Drosophila) | 5.070e-5 | 3.539e+0 |
bex6 | brain expressed gene 6 | 2.116e-4 | 3.473e+0 |
d0h4s114 | DNA segment, human D4S114 | 2.529e-6 | 3.394e+0 |
igf2bp3 | insulin-like growth factor 2 mRNA binding protein 3 | 1.846e-6 | 3.363e+0 |
zfp105 | zinc finger protein 105 | 6.246e-6 | 3.231e+0 |
tnnt1 | troponin T1, skeletal, slow | 1.973e-6 | 3.188e+0 |
2610528g24rik | RIKEN cDNA 2610528G24 gene | 6.624e-8 | 3.187e+0 |
spats2 | spermatogenesis associated, serine-rich 2 | 4.526e-6 | 3.074e+0 |
sfrp2 | secreted frizzled-related protein 2 | 6.001e-4 | 3.073e+0 |
prom1 | prominin 1 | 1.947e-4 | 3.070e+0 |
zfp711 | zinc finger protein 711 | 3.492e-4 | 3.056e+0 |
s100a16 | S100 calcium binding protein A16 | 5.453e-6 | 3.019e+0 |
hbb-y | hemoglobin Y, beta-like embryonic chain | 7.035e-3 | 2.932e+0 |
she | src homology 2 domain-containing transforming protein E | 9.062e-7 | 2.882e+0 |
acp5 | acid phosphatase 5, tartrate resistant | 3.638e-4 | 2.875e+0 |
col18a1 | collagen, type XVIII, alpha 1 | 1.019e-5 | 2.783e+0 |
shcbp1 | Shc SH2-domain binding protein 1 | 6.205e-3 | 2.721e+0 |
fn1 | fibronectin 1 | 2.422e-4 | 2.688e+0 |
rasgrp3 | RAS, guanyl releasing protein 3 | 1.381e-4 | 2.655e+0 |
id3 | inhibitor of DNA binding 3 | 2.585e-4 | 2.629e+0 |
cxcr3 | chemokine (C-X-C motif) receptor 3 | 2.588e-5 | 2.600e+0 |
apoc1 | apolipoprotein C-I | 4.418e-5 | 2.578e+0 |
heph | hephaestin | 4.386e-5 | 2.569e+0 |
st8sia1 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 | 1.414e-4 | 2.562e+0 |
d10ertd755e | DNA segment, Chr 10, ERATO Doi 755, expressed | 3.321e-4 | 2.552e+0 |
plvap | plasmalemma vesicle associated protein | 2.918e-4 | 2.517e+0 |
d2ertd173e | DNA segment, Chr 2, ERATO Doi 173, expressed | 2.054e-4 | 2.510e+0 |
loc100045217 | similar to Transmembrane protein with EGF-like and two follistatin-like domains 1 | 2.035e-6 | 2.508e+0 |
a830059i20rik | RIKEN cDNA A830059I20 gene | 3.777e-8 | 2.487e+0 |
zdbf2 | zinc finger, DBF-type containing 2 | 5.885e-6 | 2.483e+0 |
mgam | maltase-glucoamylase | 7.681e-5 | 2.473e+0 |
ect2 | ect2 oncogene | 2.109e-3 | 2.460e+0 |
igf2bp2 | insulin-like growth factor 2 mRNA binding protein 2 | 1.383e-6 | 2.457e+0 |
pxdn | peroxidasin homolog (Drosophila) | 4.592e-6 | 2.453e+0 |
3632451o06rik | RIKEN cDNA 3632451O06 gene | 2.758e-5 | 2.449e+0 |
1700010i14rik | RIKEN cDNA 1700010I14 gene | 6.745e-5 | 2.439e+0 |
wasf1 | WASP family 1 | 1.022e-4 | 2.430e+0 |
ottmusg00000000971 | predicted gene, OTTMUSG00000000971 | 1.532e-3 | 2.408e+0 |
cnr2 | cannabinoid receptor 2 (macrophage) | 1.363e-4 | 2.401e+0 |
msrb3 | methionine sulfoxide reductase B3 | 9.923e-4 | 2.372e+0 |
ndc80 | NDC80 homolog, kinetochore complex component (S. cerevisiae) | 1.452e-4 | 2.366e+0 |
gem | GTP binding protein (gene overexpressed in skeletal muscle) | 5.771e-4 | 2.362e+0 |
sh3gl3 | SH3-domain GRB2-like 3 | 2.523e-5 | 2.361e+0 |
2610029i01rik | RIKEN cDNA 2610029I01 gene | 1.046e-4 | 2.361e+0 |
cd200r4 | Cd200 receptor 4 | 1.946e-4 | 2.358e+0 |
mdk | midkine | 5.428e-5 | 2.356e+0 |
nt5dc2 | 5'-nucleotidase domain containing 2 | 3.603e-4 | 2.325e+0 |
d430019h16rik | RIKEN cDNA D430019H16 gene | 2.131e-5 | 2.319e+0 |
4632434i11rik | RIKEN cDNA 4632434I11 gene | 1.427e-3 | 2.317e+0 |
ttpa | tocopherol (alpha) transfer protein | 3.213e-5 | 2.313e+0 |
ccnb1-rs1 | cyclin B1, related sequence 1 | 3.035e-6 | 2.305e+0 |
rps4y2 | ribosomal protein S4, Y-linked 2 | 1.950e-5 | 2.305e+0 |
ptgr1 | prostaglandin reductase 1 | 8.506e-4 | 2.298e+0 |
tsix | X (inactive)-specific transcript, antisense | 3.164e-2 | 2.295e+0 |
ncapg | on-SMC condensin I complex, subunit G | 1.242e-4 | 2.263e+0 |
ndrg4 | N-myc downstream regulated gene 4 | 1.528e-3 | 2.259e+0 |
asprv1 | aspartic peptidase, retroviral-like 1 | 2.536e-5 | 2.258e+0 |
tyrobp | TYRO protein tyrosine kinase binding protein | 1.633e-3 | 2.239e+0 |
ldb2 | LIM domain binding 2 | 5.329e-5 | 2.215e+0 |
thbd | thrombomodulin | 5.402e-4 | 2.210e+0 |
ocln | occludin | 2.741e-4 | 2.205e+0 |
aurkb | aurora kinase B | 1.126e-3 | 2.192e+0 |
4930519n13rik | RIKEN cDNA 4930519N13 gene | 7.012e-3 | 2.190e+0 |
ccnb2 | cyclin B2 | 1.755e-4 | 2.188e+0 |
kmo | kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | 2.741e-5 | 2.176e+0 |
ube2c | ubiquitin-conjugating enzyme E2C | 3.246e-4 | 2.170e+0 |
slit2 | slit homolog 2 (Drosophila) | 1.133e-6 | 2.163e+0 |
plagl1 | pleiomorphic adenoma gene-like 1 | 9.783e-5 | 2.157e+0 |
4930547n16rik | RIKEN cDNA 4930547N16 gene | 1.531e-3 | 2.152e+0 |
tmem47 | transmembrane protein 47 | 7.936e-4 | 2.150e+0 |
3000004c01rik | RIKEN cDNA 3000004C01 gene | 9.963e-4 | 2.138e+0 |
bcl6b | B-cell CLL/lymphoma 6, member B | 2.267e-3 | 2.137e+0 |
lgals1 | lectin, galactose binding, soluble 1 | 1.703e-4 | 2.122e+0 |
dok2 | docking protein 2 | 4.616e-5 | 2.115e+0 |
c76336 | expressed sequence C76336 | 3.900e-3 | 2.107e+0 |
loc100044746 | similar to Kifc1 protein | 2.804e-5 | 2.106e+0 |
sgk1 | serum/glucocorticoid regulated kinase 1 | 4.568e-4 | 2.103e+0 |
bank1 | B-cell scaffold protein with ankyrin repeats 1 | 9.880e-3 | 2.098e+0 |
d930028f11rik | RIKEN cDNA D930028F11 gene | 7.483e-4 | 2.057e+0 |
2700049p18rik | RIKEN cDNA 2700049P18 gene | 7.524e-4 | 2.052e+0 |
ccnf | cyclin F | 7.555e-4 | 2.050e+0 |
ercc6l | excision repair cross-complementing rodent repair deficiency complementation group 6 - like | 5.172e-3 | 2.044e+0 |
1110059g02rik | RIKEN cDNA 1110059G02 gene | 2.882e-3 | 2.036e+0 |
phlda1 | pleckstrin homology-like domain, family A, member 1 | 4.794e-4 | 2.032e+0 |
plk4 | polo-like kinase 4 (Drosophila) | 5.900e-4 | 2.031e+0 |
2610528a11rik | RIKEN cDNA 2610528A11 gene | 8.003e-6 | 2.030e+0 |
dsp | desmoplakin | 8.970e-4 | 2.028e+0 |
1700016k19rik | RIKEN cDNA 1700016K19 gene | 9.939e-5 | 2.019e+0 |
2810417h13rik | RIKEN cDNA 2810417H13 gene | 8.834e-5 | 2.014e+0 |
6330403k07rik | RIKEN cDNA 6330403K07 gene | 4.337e-4 | 2.010e+0 |
ai449310 | expressed sequence AI449310 | 3.220e-2 | 2.009e+0 |
rps6ka6 | ribosomal protein S6 kinase polypeptide 6 | 6.075e-4 | 2.009e+0 |
sept10 | septin 10 | 7.369e-4 | 2.005e+0 |
4933439c20rik | RIKEN cDNA 4933439C20 gene | 1.880e-4 | -2.003e+0 |
otos | otospiralin | 4.533e-3 | -2.003e+0 |
ly6a | lymphocyte antigen 6 complex, locus A | 1.045e-4 | -2.008e+0 |
zbtb20 | zinc finger and BTB domain containing 20 | 1.760e-5 | -2.019e+0 |
igk-v1 | immunoglobulin kappa chain variable 1 (V1) | 2.899e-2 | -2.029e+0 |
nckap1 | NCK-associated protein 1 | 9.262e-4 | -2.032e+0 |
rai2 | retinoic acid induced 2 | 4.007e-3 | -2.043e+0 |
gstt1 | glutathione S-transferase, theta 1 | 9.340e-5 | -2.043e+0 |
gpr133 | G protein-coupled receptor 133 | 1.050e-3 | -2.059e+0 |
fbp1 | fructose bisphosphatase 1 | 2.165e-3 | -2.073e+0 |
gbp2 | guanylate binding protein 2 | 7.923e-5 | -2.078e+0 |
foxred2 | FAD-dependent oxidoreductase domain containing 2 | 4.808e-4 | -2.086e+0 |
9530053h05rik | RIKEN cDNA 9530053H05 gene | 1.130e-3 | -2.088e+0 |
serpinb1a | serine (or cysteine) peptidase inhibitor, clade B, member 1a | 5.279e-5 | -2.097e+0 |
h2-dmb1 | histocompatibility 2, class II, locus Mb1 | 8.291e-4 | -2.115e+0 |
bdh2 | 3-hydroxybutyrate dehydrogenase, type 2 | 2.080e-3 | -2.139e+0 |
sdpr | serum deprivation response | 4.705e-3 | -2.146e+0 |
dkkl1 | dickkopf-like 1 | 1.009e-5 | -2.152e+0 |
d130051d11rik | RIKEN cDNA D130051D11 gene | 6.689e-4 | -2.152e+0 |
ifi44 | interferon-induced protein 44 | 1.201e-3 | -2.159e+0 |
9530019h20rik | RIKEN cDNA 9530019H20 gene | 1.254e-2 | -2.162e+0 |
npr2 | natriuretic peptide receptor 2 | 3.002e-5 | -2.163e+0 |
slc6a15 | solute carrier family 6 (neurotransmitter transporter), member 15 | 5.894e-3 | -2.164e+0 |
2310050p20rik | RIKEN cDNA 2310050P20 gene | 1.059e-2 | -2.176e+0 |
smarca2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 1.309e-7 | -2.183e+0 |
pdgfrb | platelet derived growth factor receptor, beta polypeptide | 1.358e-4 | -2.185e+0 |
insl6 | insulin-like 6 | 2.062e-5 | -2.187e+0 |
cpt1a | carnitine palmitoyltransferase 1a, liver | 2.631e-5 | -2.189e+0 |
trp53i11 | transformation related protein 53 inducible protein 11 | 1.919e-4 | -2.189e+0 |
rab20 | RAB20, member RAS oncogene family | 5.693e-4 | -2.202e+0 |
padi4 | peptidyl arginine deiminase, type IV | 8.490e-5 | -2.206e+0 |
nkg7 | natural killer cell group 7 sequence | 6.933e-4 | -2.239e+0 |
2310051e17rik | RIKEN cDNA 2310051E17 gene | 2.732e-7 | -2.247e+0 |
hdgfrp3 | hepatoma-derived growth factor, related protein 3 | 4.850e-5 | -2.256e+0 |
tacstd2 | tumor-associated calcium signal transducer 2 | 2.155e-3 | -2.259e+0 |
3021401c12rik | RIKEN cDNA 3021401C12 gene | 1.118e-3 | -2.292e+0 |
nfia | nuclear factor I/A | 3.033e-3 | -2.292e+0 |
ptger4 | prostaglandin E receptor 4 (subtype EP4) | 2.215e-4 | -2.304e+0 |
col16a1 | collagen, type XVI, alpha 1 | 1.399e-8 | -2.307e+0 |
ndrg1 | N-myc downstream regulated gene 1 | 2.216e-4 | -2.334e+0 |
il18 | interleukin 18 | 1.892e-5 | -2.357e+0 |
cyp2j6 | cytochrome P450, family 2, subfamily j, polypeptide 6 | 4.266e-4 | -2.366e+0 |
plscr2 | phospholipid scramblase 2 | 4.884e-3 | -2.370e+0 |
eg381438 | predicted gene, EG381438 | 2.741e-4 | -2.371e+0 |
casp1 | caspase 1 | 2.289e-5 | -2.387e+0 |
foxa3 | forkhead box A3 | 1.082e-4 | -2.390e+0 |
a630077b13rik | RIKEN cDNA A630077B13 gene | 3.061e-4 | -2.412e+0 |
casp12 | caspase 12 | 2.741e-4 | -2.416e+0 |
gpx7 | glutathione peroxidase 7 | 3.346e-5 | -2.419e+0 |
bhlhb2 | basic helix-loop-helix domain containing, class B2 | 1.808e-4 | -2.435e+0 |
muc13 | mucin 13, epithelial transmembrane | 6.360e-6 | -2.462e+0 |
cd72 | CD72 antigen | 7.492e-5 | -2.469e+0 |
pf4 | platelet factor 4 | 3.261e-5 | -2.472e+0 |
b230317c12rik | RIKEN cDNA B230317C12 gene | 5.661e-4 | -2.491e+0 |
clec2d | C-type lectin domain family 2, member d | 2.287e-3 | -2.499e+0 |
plscr4 | phospholipid scramblase 4 | 1.441e-5 | -2.511e+0 |
c1r | complement component 1, r subcomponent | 1.001e-4 | -2.518e+0 |
upp1 | uridine phosphorylase 1 | 3.567e-4 | -2.563e+0 |
ltbp3 | latent transforming growth factor beta binding protein 3 | 4.306e-6 | -2.599e+0 |
tnfsf4 | tumor necrosis factor (ligand) superfamily, member 4 | 2.732e-4 | -2.627e+0 |
kazald1 | Kazal-type serine peptidase inhibitor domain 1 | 1.759e-5 | -2.642e+0 |
cadps2 | Ca2+-dependent activator protein for secretion 2 | 2.622e-4 | -2.651e+0 |
calml4 | calmodulin-like 4 | 3.462e-4 | -2.663e+0 |
2210023g05rik | RIKEN cDNA 2210023G05 gene | 3.770e-6 | -2.668e+0 |
csgalnact1 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | 6.805e-5 | -2.691e+0 |
bgn | biglycan | 5.467e-6 | -2.697e+0 |
h2-dma | histocompatibility 2, class II, locus DMa | 3.775e-7 | -2.705e+0 |
cd74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | 2.165e-4 | -2.728e+0 |
galnt6 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 | 1.326e-5 | -2.751e+0 |
6330403m23rik | RIKEN cDNA 6330403M23 gene | 1.250e-4 | -2.831e+0 |
alcam | activated leukocyte cell adhesion molecule | 5.083e-7 | -2.864e+0 |
ripply3 | ripply3 homolog (zebrafish) | 2.533e-5 | -2.871e+0 |
npdc1 | neural proliferation, differentiation and control gene 1 | 1.164e-4 | -2.910e+0 |
lhcgr | luteinizing hormone/choriogonadotropin receptor | 1.600e-5 | -2.922e+0 |
pqlc3 | PQ loop repeat containing | 8.131e-5 | -2.928e+0 |
h2-eb1 | histocompatibility 2, class II antigen E beta | 1.407e-5 | -2.943e+0 |
egr1 | early growth response 1 | 2.653e-4 | -3.021e+0 |
ensmusg00000055440 | predicted gene, ENSMUSG00000055440 | 6.717e-5 | -3.035e+0 |
mpa2l | macrophage activation 2 like | 5.894e-4 | -3.057e+0 |
iigp1 | interferon inducible GTPase 1 | 6.240e-6 | -3.075e+0 |
tgtp | T-cell specific GTPase | 1.648e-5 | -3.093e+0 |
clec1a | C-type lectin domain family 1, member a | 1.996e-4 | -3.153e+0 |
1100001g20rik | RIKEN cDNA 1100001G20 gene | 8.567e-3 | -3.173e+0 |
esr1 | estrogen receptor 1 (alpha) | 3.016e-6 | -3.229e+0 |
d630039a03rik | RIKEN cDNA D630039A03 gene | 2.029e-5 | -3.260e+0 |
nlrc5 | NLR family, CARD domain containing 5 | 6.379e-6 | -3.352e+0 |
2310043n10rik | RIKEN cDNA 2310043N10 gene | 4.762e-4 | -3.446e+0 |
car1 | carbonic anhydrase 1 | 6.308e-4 | -3.483e+0 |
lair1 | leukocyte-associated Ig-like receptor 1 | 7.719e-6 | -3.508e+0 |
ngp | neutrophilic granule protein | 8.894e-4 | -3.521e+0 |
h2-aa | histocompatibility 2, class II antigen A, alpha | 2.487e-5 | -3.559e+0 |
mylc2pl | myosin light chain 2, precursor lymphocyte-specific | 1.077e-3 | -3.725e+0 |
5830443l24rik | RIKEN cDNA 5830443L24 gene | 4.787e-5 | -3.795e+0 |
rmcs5 | response to metastatic cancers 5 | 6.669e-6 | -3.814e+0 |
ctss | cathepsin S | 3.300e-4 | -3.894e+0 |
a730056i06rik | RIKEN cDNA A730056I06 gene | 1.427e-6 | -4.001e+0 |
gda | guanine deaminase | 4.450e-5 | -4.063e+0 |
chi3l3 | chitinase 3-like 3 | 4.280e-5 | -4.181e+0 |
sdsl | serine dehydratase-like | 4.418e-7 | -4.213e+0 |
cpne2 | copine II | 1.238e-5 | -4.225e+0 |
aw112010 | expressed sequence AW112010 | 5.563e-7 | -4.231e+0 |
sult1a1 | sulfotransferase family 1A, phenol-preferring, member 1 | 2.899e-5 | -4.495e+0 |
camp | cathelicidin antimicrobial peptide | 3.852e-4 | -4.759e+0 |
h2-q8 | histocompatibility 2, Q region locus 8 | 1.829e-5 | -4.887e+0 |
4930519l02rik | RIKEN cDNA 4930519L02 gene | 3.302e-7 | -5.063e+0 |
fos | FBJ osteosarcoma oncogene | 5.685e-4 | -5.168e+0 |
rgs1 | regulator of G-protein signaling 1 | 6.167e-9 | -5.224e+0 |
tnfsf13 | tumor necrosis factor (ligand) superfamily, member 13 | 5.653e-7 | -5.312e+0 |
h2-gs10 | MHC class I like protein GS10 | 9.911e-7 | -5.646e+0 |
aldh1a1 | aldehyde dehydrogenase family 1, subfamily A1 | 8.909e-6 | -6.290e+0 |
h2-q7 | histocompatibility 2, Q region locus 7 | 1.491e-8 | -6.679e+0 |
0610037m15rik | RIKEN cDNA 0610037M15 gene | 4.996e-9 | -7.173e+0 |
s100a9 | S100 calcium binding protein A9 (calgranulin B) | 4.322e-6 | -7.739e+0 |
s100a8 | S100 calcium binding protein A8 (calgranulin A) | 5.149e-6 | -7.999e+0 |